Lonza names new CEO
Ridinger will be responsible for strengthening Lonza’s market position in relevant markets, competitive capabilities, and productivity improvement in critical areas. Ridinger has held several roles at Henkel and
Novartis has entered a collaboration with Chai Discovery to advance the use of AI in the identification of therapeutic antibodies.
Under the collaboration, the companies will produce ADCs by integrating PolyTherics’ proprietary TheraPEG linker technology with Spirogen’s pyrrolobenzodiazepines (PBDs) cytotoxic agents. The companies will then evaluate the potency
Codexis Pharmaceuticals senior vice president Peter Seufer-Wasserthal said the Codexis technology has delivered solid results including the reduction in production costs for boceprevir. Codexis employed its proprietary CodeEvolver